RT Journal Article
SR Electronic
T1 Individual variation in susceptibility or exposure to SARS-CoV-2 lowers the herd immunity threshold
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.27.20081893
DO 10.1101/2020.04.27.20081893
A1 Gomes, M. Gabriela M.
A1 Ferreira, Marcelo U.
A1 Corder, Rodrigo M.
A1 King, Jessica G.
A1 Souto-Maior, Caetano
A1 Penha-Gonçalves, Carlos
A1 Gonçalves, Guilherme
A1 Chikina, Maria
A1 Pegden, Wesley
A1 Aguas, Ricardo
YR 2022
UL http://medrxiv.org/content/early/2022/02/14/2020.04.27.20081893.abstract
AB Individual variation in susceptibility and exposure is subject to selection by natural infection, accelerating the acquisition of immunity, and reducing herd immunity thresholds and epidemic final sizes. This is a manifestation of a wider population phenomenon known as “frailty variation”. Despite theoretical understanding, public health policies continue to be guided by mathematical models that leave out considerable variation and as a result inflate projected disease burdens and overestimate the impact of interventions. Here we focus on trajectories of the coronavirus disease (COVID-19) pandemic in England and Scotland until November 2021. We fit models to series of daily deaths and infer relevant epidemiological parameters, including coefficients of variation and effects of non-pharmaceutical interventions which we find in agreement with independent empirical estimates based on contact surveys. Our estimates are robust to whether the analysed data series encompass one or two pandemic waves and enable projections compatible with subsequent dynamics. We conclude that vaccination programmes may have contributed modestly to the acquisition of herd immunity in populations with high levels of pre-existing naturally acquired immunity, while being critical to protect vulnerable individuals from severe outcomes as the virus becomes endemic.HighlightsVariation in susceptibility/exposure responds to selection by natural infectionSelection on susceptibility/exposure flattens epidemic curvesModels with incomplete heterogeneity overestimate intervention impactsIndividual variation lowered the natural herd immunity threshold for SARS-CoV-2Competing Interest StatementThe authors have declared no competing interest.Funding StatementNo external funding was received.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript are publicly available.